AstraZeneca Set For Boston Area Growth Spurt
This article was originally published in The Pink Sheet Daily
$100 million expansion will add 132,000 square feet of lab space for research in infectious disease and cancer by 2009.
You may also be interested in...
Genentech joins Pfizer and AstraZeneca in developing the new class of oncology compounds.
Cubist is in talks with potential partners for Japanese rights, which the firm has retained.
The Devens, Mass. facility will allow the firm to increase production of the rheumatoid arthritis product Orencia (abatacept).